Literature DB >> 2505917

Meningococcal disease in Canada: surveillance summary to 1987.

P V Varughese1.   

Abstract

Meningococcal disease continues to occur in most parts of Canada at endemic levels, with minor fluctuations. The incidence in general has changed very little over the past three decades. It is primarily a childhood infection, occurring most commonly among infants less than 1 year of age. In 1987 the risk of infection among infants in that age group was 4 times and among those aged 1 to 4 years 2.5 times that of the general population. The most susceptible appear to be infants about 3 months of age. The annual CFRs had exceeded 50% before the antibiotic era, but with early diagnosis, modern therapy and supportive measures they have been less than 10%. A revised form for reporting cases, currently being considered by provincial epidemiologists across Canada, could help to provide more clinical and epidemiologic information.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505917      PMCID: PMC1451344     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  1 in total

1.  Meningococcal group B vaccine trial in Norway 1981--1982. Preliminary report of results available November 1982.

Authors:  L O Frøholm; B P Berdal; K Bøvre; P Gaustad; A Harboe; E Holten; E A Høiby; A Lystad; T Omland; C E Frasch
Journal:  NIPH Ann       Date:  1983-12
  1 in total
  1 in total

Review 1.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.